Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014 2015 2016 2017 2018

Details for Mechanism ID: 16626
Country/Region: Uganda
Year: 2015
Main Partner: Cardno Emerging Markets
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $6,639,080 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,268,476
Care: Orphans and Vulnerable Children (HKID) $1,659,164
Care: TB/HIV (HVTB) $262,395
Care: Pediatric Care and Support (PDCS) $255,010
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $436,313
Testing: HIV Testing and Counseling (HVCT) $282,448
Sexual Prevention: Other Sexual Prevention (HVOP) $0
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $175,626
Treatment: Adult Treatment (HTXS) $2,197,455
Treatment: Pediatric Treatment (PDTX) $102,193
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 16,993
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,724
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 33,177
CARE_CURR Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 2,047
CARE_CURR Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 53,941
CARE_CURR Sum of Aggregated Age/Sex disaggregates 2016 53,941
CARE_NEW Aggregated Age/sex: <15 Female 2016 145
CARE_NEW Aggregated Age/sex: <15 Male 2016 129
CARE_NEW Aggregated Age/sex: 15+ Female 2016 2,442
CARE_NEW Aggregated Age/sex: 15+ Male 2016 1,332
CARE_NEW Number of HIV-infected adults and children newly enrolled in clinical care during the reporting period and received at least one of the following at enrollment: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 4,048
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 4,048
CARE_NEW Sum of Aggregated Age/sex disaggregates 2016 4,048
FN_THER Aggregated Age: <18 2016 500
FN_THER Aggregated Age: 18+ 2016 795
FN_THER Number of clinically malnourished PLHIV who received therapeutic and/or supplementary food during the reporting period 2016 1,295
FN_THER Number of PLHIV who were nutritionally assessed and found to be clinically undernourished 2016 16,182
FN_THER Sum of Aggregated Age disaggregates 2016 1,295
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2016 2,337
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 1,760
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2016 5,782
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 17,807
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2016 58,471
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 12,840
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2016 42,149
HTS_TST By Test Result: Negative 2016 33,589
HTS_TST By Test Result: Negative 2016 110,093
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2016 34,744
HTS_TST Sum of Aggregated Age/Sex <15 2016 4,097
HTS_TST Sum of Aggregated Age/Sex <15 2016 13,450
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 30,647
HTS_TST Sum of Aggregated Age/Sex 15+ 2016 100,620
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 34,744
HTS_TST Sum of Aggregated Age/Sex disaggregates 2016 114,070
HTS_TST Sum of Test Result disaggregates 2016 34,744
HTS_TST Sum of Test Result disaggregates 2016 114,070
HTS_TST_POS By Test Result: Positive 2016 1,155
HTS_TST_POS By Test Result: Positive 2016 3,977
OVC_ACC Number of active beneficiaries receiving support from PEPFAR OVC programs to access HIV services 2016 23,490
OVC_SERV Number of active beneficiaries served by PEPFAR OVC programs for children and families affected by HIV/AIDS 2016 45,707
PMTCT_ARV Number of HIV- positive pregnant women identified in the reporting period (including known HIV-positive at entry) 2016 1,362
PMTCT_ARV Number of HIV-positive pregnant women who received antiretrovirals to reduce risk of mother-to-child-transmission (MTCT) during pregnancy and delivery 2016 1,362
PMTCT_ARV Sub-Disag of Life-long ART: Already on treatment at the beginning of the current pregnancy 2016 1,113
PMTCT_ARV Sub-Disag of Life-long ART: Newly initiated on treatment during the current pregnancy 2016 249
PMTCT_ARV Sum of New and Current disaggregates 2016 1,362
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2016 115
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2016 1,109
PMTCT_EID Sum of Infant Age disaggregates 2016 1,109
PMTCT_STAT By: Known positives at entry 2016 1,110
PMTCT_STAT By: Number of new positives identified 2016 252
PMTCT_STAT Number of new ANC and L&D clients 2016 16,740
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2016 15,945
PMTCT_STAT Sum of Positives Status disaggregates 2016 1,362
PP_PREV Age/sex: 10-14 Female 2016 3,801
PP_PREV Age/sex: 10-14 Male 2016 2,940
PP_PREV Age/sex: 15-19 Female 2016 7,709
PP_PREV Age/sex: 15-19 Male 2016 6,600
PP_PREV Age/sex: 20-24 Female 2016 11,380
PP_PREV Age/sex: 20-24 Male 2016 7,830
PP_PREV Age/sex: 25-49 Female 2016 16,382
PP_PREV Age/sex: 25-49 Male 2016 12,627
PP_PREV Age/sex: 50+ Female 2016 1,096
PP_PREV Age/sex: 50+ Male 2016 970
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2016 71,335
PP_PREV Sum of Age/Sex disaggregates 2016 71,335
TB_ART Aggregated Age: <15 2016 37
TB_ART Aggregated Age: 15+ 2016 482
TB_ART Female 2016 332
TB_ART Known HIV-positive 2016 234
TB_ART Male 2016 187
TB_ART Sum of Aggregated Age disaggregates 2016 519
TB_ART Sum of Sex disaggregates 2016 519
TB_ART Sum of Test Status disaggregates 2016 234
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2016 646
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2016 519
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: <15 2016 3,774
TB_SCREEN Aggregated Age - USE WITH HQ PERMISSION ONLY: 15+ 2016 50,167
TB_SCREEN Number of HIV positive adults and children who received at least one of the following during the reporting period: clinical assessment (WHO staging) OR CD4 count OR viral load 2016 53,941
TB_SCREEN Sex: Female 2016 35,208
TB_SCREEN Sex: Male 2016 18,733
TB_SCREEN Sum of Aggregated Age disaggregates 2016 53,941
TB_SCREEN Sum of Sex disaggregates 2016 53,941
TX_CURR Aggregated Age/Sex: 15+ Female 2016 14,713
TX_CURR Aggregated Age/Sex: 15+ Male 2016 31,970
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2016 50,392
TX_CURR Sum of Aggregated Age/Sex 15+ 2016 46,683
TX_CURR Sum of Aggregated Age/Sex disaggregates 2016 46,683
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2016 1,850
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2016 3,895
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2016 6,000
TX_NEW Sum of Aggregated Age/Sex disaggregates 2016 5,745
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2016 4,622
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2016 5,442
VMMC_AE Number of males circumcised surgically or by medical device that experienced at least one moderate or severe adverse event(s) (AEs) 2016 41
VMMC_CIRC By circumcision technique: Surgical VMMC 2016 12,500
VMMC_CIRC By follow-up status: Number of surgically circumcised clients who returned at least once for follow-up care within 14 days of circumcision surgery 2016 12,500
VMMC_CIRC By HIV status: Number of clients with undocumented/indeterminate HIV status or not tested for HIV at site 2016 2,750
VMMC_CIRC By HIV status: Number of HIV-negative clients (tested HIV negative at VMMC program) 2016 9,524
VMMC_CIRC By HIV status: Number of HIV-positive clients (tested HIV positive at VMMC site) 2016 227
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2016 12,500